The longitudinal study of relationship between changes in cognitive function and beta amyloid accumulation in the brain using 11C-Pib PET
Not Applicable
- Conditions
- Alzheimer disease, mild cognitive decline, preclinical Alzheimer disease
- Registration Number
- JPRN-UMIN000030430
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
Depression patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 11C-PiB PET, FDG-PET and cognitive tests are performed every year and followed for three years. PiB PET shows accumulation of beta amyloid protein, and FDG PET reveals glucose metabolisms in the brain. As cognitive batteries, MMSE, FAB, MoCA-J and WMSR are performed.
- Secondary Outcome Measures
Name Time Method